Canada markets closed

Clover Health Investments, Corp. (CLOV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.62+0.39 (+4.74%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close8.23
Open8.39
Bid8.63 x 2200
Ask8.68 x 1200
Day's Range8.25 - 8.91
52 Week Range6.31 - 17.45
Volume6,425,859
Avg. Volume24,331,738
Market Cap3.502B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.67
  • Clover Health to Report First Quarter 2021 Financial Results on May 17, 2021
    GlobeNewswire

    Clover Health to Report First Quarter 2021 Financial Results on May 17, 2021

    NASHVILLE, Tenn., April 28, 2021 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV), an innovative technology company improving health outcomes for America's seniors, today announced that it will report first quarter 2021 financial results prior to market open on Monday, May 17, 2021. Management will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the company’s business and financial results. First Quarter Conference Call and Webcast Details What: Clover Health First Quarter 2021 Earnings Conference CallWhen: Monday, May 17, 2021, at 8:30 a.m. ETDial In: To access the conference call via telephone please dial (833) 693-0547 or (661) 407-1587 for callers outside the United States and enter the conference ID 6667897Webcast: A live and archived webcast of the conference call will be accessible from the Investor Relations section of the company’s website at https://investors.cloverhealth.com/ for twelve months until May 17, 2022. About Clover Health Clover Health is a healthcare technology company with a deeply rooted mission of helping its members live their healthiest lives. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. As a company whose business goals fully align with its members' health needs, Clover works with members and their doctors to become a valued partner. This trust is built by proactively identifying at-risk individuals and teaming up with physicians to accelerate care coordination and simultaneously improve health outcomes and reduce avoidable costs. Clover has offices in Nashville, San Francisco, Jersey City, and Hong Kong. For more information, visit www.CloverHealth.com. Contacts: Investor Relations:investors@cloverhealth.com Press Contact:Andrew Still-Baxterpress@cloverhealth.com

  • Shareholder Alert: Robbins LLP is Investigating Clover Health Investments, Corp. (CLOV) on Behalf of Shareholders
    Business Wire

    Shareholder Alert: Robbins LLP is Investigating Clover Health Investments, Corp. (CLOV) on Behalf of Shareholders

    Shareholder rights law firm Robbins LLP is investigating Clover Health Investments, Corp. (NASDAQ: CLOV) on behalf of shareholders to determine whether certain Clover officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. Clover Health provides medical insurance services.

  • Bragar Eagel & Squire is Investigating Certain Officers and Directors of Merit Medical Systems, Clover Health, and Zoom on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    GlobeNewswire

    Bragar Eagel & Squire is Investigating Certain Officers and Directors of Merit Medical Systems, Clover Health, and Zoom on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

    NEW YORK, April 22, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Merit Medical Systems, Inc. (NASDAQ: MMSI), Clover Health Investments Corp. (NASDAQ: CLOV), and Zoom Video Communications, Inc. (NASDAQ: ZM) on behalf of long-term stockholders. More information about each potential case can be found at the link provided. Merit Medical Systems, Inc. (NASDAQ: MMSI) Bragar Eagel & Squire is investigating certain officers and directors of Merit Medical Systems, Inc. following news that the Shareholder Class Action against Merit Medical has survived the motions to dismiss in the pending securities class action and may face damages. According to the securities class action complaint, during the class period defendants made false and misleading statements and/or failed to disclose adverse information concerning Merit’s business and prospects. Specifically, defendants failed to disclose that: (a) the integrations of Cianna and Vascular Insights, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (b) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during fiscal 2019; and (c) in light of the foregoing, the Company’s reported financial guidance for fiscal 2019 and 2020 was made without a reasonable basis. As a result of defendants’ material misrepresentations and omissions, Merit stock traded at artificially inflated prices of more than $62 per share. On March 29, 2021, U.S. District Judge David O. Carter denied defendants’ motions to dismiss plaintiffs’ claims, finding that plaintiffs had plausibly alleged securities fraud claims. For more information on our investigation into Merit Medical go to: https://bespc.com/cases/mmsi Clover Health Investments Corp. (NASDAQ: CLOV) Bragar Eagel & Squire is investigating certain officers and directors of Clover Health Investments Corp. following a class action complaint that was filed against Clover on February 5, 2021. The complaint alleges that throughout the class period defendants made materially false and misleading statements regarding the Company’s business. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) Clover was the recipient of a Civil Investigative Demand from the DOJ; (ii) much of Clover’s sales are driven by a major related party deal that Clover not only failed to disclose but took active steps to conceal; (iii) Clover’s subsidiary Seek Insurance failed to disclose its relationship with Clover and misled consumers as to its purported independence; (iv) Clover’s software was in fact rudimentary; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times. For more information on our investigation into Clover go to: https://bespc.com/cases/clover Zoom Video Communications, Inc. (NASDAQ: ZM) Bragar Eagel & Squire is investigating certain officers and directors of Zoom Video Communications, Inc. following a class action complaint that was filed against Zoom on April 7, 2020. The Complaint alleges that throughout the Class Period defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) Zoom had inadequate data privacy and security measures; (ii) contrary to Zoom’s assertions, the Company’s video communications service was not end-to-end encrypted; (iii) as a result of all the foregoing, users of Zoom’s communications services were at an increased risk of having their personal information accessed by unauthorized parties, including Facebook; (iv) usage of the Company’s video communications services was foreseeably likely to decline when the foregoing facts came to light; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times. For more information on our investigation into Zoom go to: https://bespc.com/cases/ZM About Bragar Eagel & Squire, P.C.:Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Contact Information:Bragar Eagel & Squire, P.C.Brandon Walker, Esq. Melissa Fortunato, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com